Skip to main content
Research partnership aims to develop new treatments for diabetes

A research partnership between biotechnology company Thermalin and pharmaceutical firm Sanofi for new insulin treatments for diabetes is expected to produce up to $788 million. The companies will focus on developing ways to transform insulin molecules to better treat the condition.

Full Story: